Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 318

1.

Regulatory T cells, tumour immunity and immunotherapy.

Zou W.

Nat Rev Immunol. 2006 Apr;6(4):295-307. Review.

PMID:
16557261
2.

Regulatory T cells: potential target in anticancer immunotherapy.

Juang CM, Hung CF, Yeh JY, Horng HC, Twu NF, Cheng MH, Wen KC, Yuan CC, Chao KC, Wu TC, Yen MS.

Taiwan J Obstet Gynecol. 2007 Sep;46(3):215-21. Review.

3.

CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.

Wang RF.

Hum Immunol. 2008 Nov;69(11):811-4. doi: 10.1016/j.humimm.2008.08.276. Epub 2008 Sep 24. Review.

PMID:
18817828
4.

Reversal of tumor-mediated immunosuppression.

Vieweg J, Su Z, Dahm P, Kusmartsev S.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):727s-732s. Review.

5.

Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.

Flacher V, Sparber F, Tripp CH, Romani N, Stoitzner P.

Cancer Immunol Immunother. 2009 Jul;58(7):1137-47. doi: 10.1007/s00262-008-0563-9. Epub 2008 Aug 2.

PMID:
18677477
6.

TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.

Conroy H, Marshall NA, Mills KH.

Oncogene. 2008 Jan 7;27(2):168-80. doi: 10.1038/sj.onc.1210910. Review.

PMID:
18176598
7.

Tumor resistance to CD8+ T cell-based therapeutic vaccination.

Huang Y, Shah S, Qiao L.

Arch Immunol Ther Exp (Warsz). 2007 Jul-Aug;55(4):205-17. Epub 2007 Jul 23. Review.

PMID:
17659376
8.

CD8+ T cell tolerance and cancer immunotherapy.

De Visser KE, Schumacher TN, Kruisbeek AM.

J Immunother. 2003 Jan-Feb;26(1):1-11. Review.

PMID:
12514424
9.

Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?

Zhang L, Dermawan KT, Jin ML, Xiong SD, Chu YW.

Med Hypotheses. 2008 Nov;71(5):802-4. doi: 10.1016/j.mehy.2008.06.022. Epub 2008 Aug 8.

PMID:
18691831
10.

Regulatory T cells: overcoming suppression of T-cell immunity.

Golovina TN, Vonderheide RH.

Cancer J. 2010 Jul-Aug;16(4):342-7. doi: 10.1097/PPO.0b013e3181eb336d. Review.

PMID:
20693845
11.

Regulatory T cells--the renaissance of the suppressor T cells.

Bopp T, Jonuleit H, Schmitt E.

Ann Med. 2007;39(5):322-34. Review.

PMID:
17701475
12.

T-regulatory cells in tumour-specific vaccination strategies.

Welters MJ, Piersma SJ, van der Burg SH.

Expert Opin Biol Ther. 2008 Sep;8(9):1365-79. doi: 10.1517/14712598.8.9.1365 . Review.

PMID:
18694355
13.

The role of T lymphocytes in the immunotherapy of tumours.

Brondz BD, Balashov KE.

Biomed Sci. 1991;2(5):441-9. Review.

PMID:
1840832
14.

Regulatory T cells and cancer.

Wang HY, Wang RF.

Curr Opin Immunol. 2007 Apr;19(2):217-23. Epub 2007 Feb 15. Review.

PMID:
17306521
15.

Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer.

Loddenkemper C, Hoffmann C, Stanke J, Nagorsen D, Baron U, Olek S, Huehn J, Ritz JP, Stein H, Kaufmann AM, Schneider A, Cichon G.

Cancer Sci. 2009 Jun;100(6):1112-7.

PMID:
19514119
16.

Guiding the "misguided" - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours.

Huang FP, Chen YX, To CK.

Eur J Immunol. 2011 Jan;41(1):18-25. doi: 10.1002/eji.201040543. Epub 2010 Dec 9. Review.

17.

Immunoregulatory T cells: role and potential as a target in malignancy.

Beyer M, Schultze JL.

Curr Oncol Rep. 2008 Mar;10(2):130-6. Review.

PMID:
18377826
18.

Regulatory T cells: magic bullets for immunotherapy?

Frey O, Bräuer R.

Arch Immunol Ther Exp (Warsz). 2006 Jan-Feb;54(1):33-43. Epub 2006 Feb 13. Review.

PMID:
16642255
19.

Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.

Spreafico F, Mantovani A.

Pathobiol Annu. 1981;11:177-95. Review. No abstract available.

PMID:
6460217
20.

Regulatory T cells: major players in the tumor microenvironment.

Beyer M, Schultze JL.

Curr Pharm Des. 2009;15(16):1879-92. Review.

PMID:
19519430

Supplemental Content

Support Center